Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

Koca, Özlem; ÇINAR TANRIVERDİ, ESRA; ÖZKURT, Zülal; ÇALIKOĞLU, ELİF OKŞAN; kamalak, zeynep; ALAY, HANDAN; Kadıoğlu, Berrin Göktuğ

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

Esra ÇINAR TANRIVERDİ, (Atatürk Üniversitesi, Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Erzurum, Türkiye)

Zülal ÖZKURT, (Atatürk Üniversitesi, Tıp Fakültesi, Enfeksiyon Hastalıkları Anabilim Dalı, Erzurum, Türkiye)

Berrin GÖKTUĞ KADIOĞLU, (Nenehatun Kadın Doğum Hastanesi, Kadın Hastalıkları ve Doğum Bölümü, Erzurum, Türkiye)

Handan ALAY, (Nenehatun Kadın Doğum Hastanesi, Enfeksiyon Hastalıkları Anabilim Dalı, Erzurum, Türkiye)

ELİF OKŞAN ÇALIKOĞLU, (Atatürk Üniversitesi, Tıp Fakültesi, Halk Sağlığı Anabilim Dalı, Erzurum, Türkiye)

Özlem KOCA, (Atatürk Bölge Hastanesi, Mikrobiyoloji Anabilim Dalı, Antalya, Türkiye)

Zeynep KAMALAK (Buhara Hastanesi, Kadın Hastalıkları ve Doğum Kliniği, Erzurum, Türkiye)

Turkish Journal of Gastroenterology

6 1

Yıl: 2019 Cilt: 30 Sayı: 3 Sayfa Aralığı: 260 - 265 Metin Dili: İngilizce İndeks Tarihi: 29-05-2019

Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey

Öz:

Background/Aims: The vertical transmission of hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections are essential public health problems. In this study, we aimed to investigate the seroprevalence of the aforementioned infectionsamong pregnant women.Materials and Methods: This study was done retrospectively on pregnant women who presented for antenatal follow-up and delivery between 2013 and 2016. Data were collected from the hospital’s electronic health records and patient files. Blood samples were analyzedat the microbiology laboratory of the hospital. HBsAg, anti-HBs, anti-HCV, and anti-HIV titers were tested using the chemiluminescenceenzyme immunoassay method (Architect, Abbott Laboratories, USA).Results: HBsAg and anti-HBs levels were tested in 35,295 pregnant women aged 18-45 years. The HBsAg and anti-HBs levels were positivein 425 (1.2%) and 9583 (27.7%) patients, respectively. From 2013 to 2016, the HBV carrier rates have continuously decreased from 1.4% to0.8%, whereas the anti-HBs positivity has increased from 25.4% to 30.2%. Anti-HCV was detected in 6 of the 9709 (0.06%) patients. Allthe 7113 pregnant women screened for HIV showed negative results.Conclusion: Hepatitis B carrier rates among pregnant women gradually decreased with a simultaneous increase in the immunity rates. HCVseroprevalence was low and HIV positivity was not encountered in the study population.

Anahtar Kelime:

Konular: Gastroenteroloji ve Hepatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

World Health Organization, Global Hepatitis Report 2017. (http:// www.who.int/hepatitis/publications/global-hepatitis-report2017/ en/) accessed 06/02/2018.
Dinsmoor MJ. Hepatitis in the obstetric patients. Infect Dis Clin North Am 1997; 11: 77-91. [CrossRef]
Aktuğ Demir N, Asan A, Ayaz C, et al. Management of Chronic Hepatitis B in Pregnancy: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases. Klimik Journal 2013; 26(Suppl 1): 12-9. [CrossRef]
Cunningham GF, Gant NF, Leveno KJ, et al. Gastrointestinal Disorders. In: Williams Obstetrics, 21st ed. New York: McGraw-Hill, 2001; pp: 1273-1306.
Tosone G, Maraolo AE, Mascolo S, et al. Vertical hepatitis C virus transmission: Main questions and answers. World J Hepatol 2014; 6: 538-48. [CrossRef]
Yeung CY, Lee HC, Chan WT, et al. Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol 2014; 6: 643-51. [CrossRef]
Mistik R, Balik I. Epidemiological analysis of viral hepatitis in Turkey. In: Kılıçturgay K, Badur S editors. Viral Hepatitis. İstanbul: Medikal Sağlık ve Yayıncılık, 2001; p:10-55.
Wasmuth JC. HepatitisB-epidemiology, transmission and natural history. In: Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, editors. Hepatology. Dusseldorf: Flying Publisher; 2009, p: 25-36.
Xiao XM, Li AZ, Chen X, et al. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96: 167-70. [CrossRef]
Grosheide PM, Wladimiroff JW, Heijtink RA, et al. Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Br Med J 1995; 311: 1197. [CrossRef]
Bal A, Petrova A. Single Clinical Practice’s Report of Testing Initiation, Antibody Clearance, and Transmission of Hepatitis C Virus (HCV) in Infants of Chronically HCV Infected Mothers. Open Forum Infect Dis 2016; 3: ofw021.
Thomas, SL, Newell ML, Peckham CS, et al. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998; 27: 108-20. [CrossRef]
Reddick KL, Jhaveri R, Gandhi M, et al. Pregnancy outcomes associated with viral hepatitis. J Viral Hepat 2011; 18: e394-8. [CrossRef]
Pergam SA, Wang CC, Gardella CM, et al. Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol 2008; 199: 38.e1-9. [CrossRef]
Buresi MC, Lee J, Gill S, et al. The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia. J Obstet Gynaecol Can 2010; 32: 935-41. [CrossRef]
Rimawi BH, Haddad L, Badell ML, et al. Management of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential Practices. Infect Dis Obstet Gynecol 2016; 2016: 7594306. [CrossRef]
Tosun S. Türkiye’de viral hepatit B epidemiyolojisi yayınların metaanalizi. In: Tabak F, Tosun S editors. Viral Hepatit 2013, 1. Baskı, İstanbul: Medikal Sağlık ve Yayıncılık, 2013; p 25-80. (in Turkish).
Madendağ Y, Madendağ İç: Çelen Ş, Ünlü S, Danişman N. Seroprevalence of Hepatitis B, Hepatitis C And HIV at whole obstetric and gynecologic patients who applied our hospital. J Gynecol Obst 2007; 17: 442-6. (in Turkish).
Özlü T, Tas T, Mengeloglu FZ, et al. Frequency of HBsAg, anti-HCV, and anti-HIV in pregnant women and/or patients with gynecologic diseases in a tertiary hospital. J Clin Exp Invest 2013; 4: 166-70. [CrossRef]
Parlak M, Selimoğlu M, Energin M, et al. Prevalance of Hepatitis B in pregnant women and perinatal transmission. Türkiye Klinikleri Journal of Gastroenterohepatology 1994; 5: 270-2. (in Turkish).
Kadanalı A, Celebi S, Aydos, SK, et al. Perinatal transmission of Hepatit B virus in Erzurum. AUTD 1997; 29: 450-42. (in Turkish).
Tekay F, Özbek E. Hepatitis B, Hepatitis C and Human Immunodeficiency Virus seropositivities in women admitted to Şanlıurfa Gynecology And Obstetrics Hospital. Mikrobiyol Bült 2006; 40: 369-72.
Dundar Ö, Çelik S, Tutuncu L, et al. The prevalence of Hepatitis B, Hepatitis C, HIV, toxoplasmosis and rubella among pregnant women delivered in our clinic between 2000 and 2005. Zeynep Kamil Tıp Bülteni 2009; 40: 1-9.
Cicek ÇA, Duygu F ve Inakçı IH. Hepatitis B and Hepatitis C Seropositivities in Women Admitted To Gynecology and Obstetrics Hospital in Şanlıurfa City: A 3- Year Evaluation. Viral Hepat J 2012; 18: 15-8.
Kölgelier S, Demir LS, Demir NA, et al. Seropositivity of HBsAg and anti-HCV in Pregnant Women in Adıyaman. Viral Hepat J 2012; 18: 98-101.
Furuncuoglu Y, Bolukbas FF, Bolukbas C, et al. Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation. Postgrad Med J 2016; 92: 510- 3. [CrossRef]
Mıstık R. The epidemiology of hepatitis C virus infection. In: Tabak F, Tosun S editors. Viral Hepatit 2013, 1. Baskı, İstanbul: Medikal Sağlık ve Yayıncılık, p. 2013: 83-112.
Guclu E, Ogutlu A, Karabay O. A Study on the Age-Related Changes in Hepatitis B and C Virus Serology. Eurasian J Med 2016; 48: 37-41. [CrossRef]
Surya GP, Kornia K, Suwardewa TGA. Serological markers of hepatitis B, C, E viruses and HIV type-1 infections in pregnant women in Bali, Indonesia. J Med Virol 2005; 75: 499-503. [CrossRef]
Baldo V, Fleroani A, Menegon T, et al. Hepatitis C virus, hepatitis Bvirus infection in pregnant Women in Nort-East Italy: a seroepidemiological study. Eur J Epidemiol 2000; 1: 87-91. [CrossRef]
Bertolini DA, Pinho JRR, Saraceni CP. Prevalence of serological markers of hepatitis B virus in pregnant women from Parana State, Brazil. Braz J Med Biol Res 2006; 39: 1083-90. [CrossRef]
Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population. J Obstet Gynaecol 2006; 26: 770-2. [CrossRef]
Papaevangelou V, Hadjichristodoulou C, Cassimos D. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect Dis 2006; 6: 84. [CrossRef]
Erol S, Şahin ÜA, Özkurt Z, et al. Seroprevalence of HBsAg, anti-HCV, anti-HIV and Non-treponemal syphilis antibody in blood donor at Erzurum region. J Turk Microbiol Soc 2001; 31: 245-9.

APA	ÇINAR TANRIVERDİ E, ÖZKURT Z, Kadıoğlu B, ALAY H, ÇALIKOĞLU E, Koca Ö, kamalak z (2019). Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. , 260 - 265.
Chicago	ÇINAR TANRIVERDİ ESRA,ÖZKURT Zülal,Kadıoğlu Berrin Göktuğ,ALAY HANDAN,ÇALIKOĞLU ELİF OKŞAN,Koca Özlem,kamalak zeynep Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. (2019): 260 - 265.
MLA	ÇINAR TANRIVERDİ ESRA,ÖZKURT Zülal,Kadıoğlu Berrin Göktuğ,ALAY HANDAN,ÇALIKOĞLU ELİF OKŞAN,Koca Özlem,kamalak zeynep Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. , 2019, ss.260 - 265.
AMA	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. . 2019; 260 - 265.
Vancouver	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. . 2019; 260 - 265.
IEEE	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z "Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey." , ss.260 - 265, 2019.
ISNAD	ÇINAR TANRIVERDİ, ESRA vd. "Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey". (2019), 260-265.

APA	ÇINAR TANRIVERDİ E, ÖZKURT Z, Kadıoğlu B, ALAY H, ÇALIKOĞLU E, Koca Ö, kamalak z (2019). Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology, 30(3), 260 - 265.
Chicago	ÇINAR TANRIVERDİ ESRA,ÖZKURT Zülal,Kadıoğlu Berrin Göktuğ,ALAY HANDAN,ÇALIKOĞLU ELİF OKŞAN,Koca Özlem,kamalak zeynep Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology 30, no.3 (2019): 260 - 265.
MLA	ÇINAR TANRIVERDİ ESRA,ÖZKURT Zülal,Kadıoğlu Berrin Göktuğ,ALAY HANDAN,ÇALIKOĞLU ELİF OKŞAN,Koca Özlem,kamalak zeynep Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology, vol.30, no.3, 2019, ss.260 - 265.
AMA	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology. 2019; 30(3): 260 - 265.
Vancouver	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey. Turkish Journal of Gastroenterology. 2019; 30(3): 260 - 265.
IEEE	ÇINAR TANRIVERDİ E,ÖZKURT Z,Kadıoğlu B,ALAY H,ÇALIKOĞLU E,Koca Ö,kamalak z "Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey." Turkish Journal of Gastroenterology, 30, ss.260 - 265, 2019.
ISNAD	ÇINAR TANRIVERDİ, ESRA vd. "Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey". Turkish Journal of Gastroenterology 30/3 (2019), 260-265.